On October 22, 2026, the trial ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management was listed with a status of recruiting. The study is registered as NCT07517042 and is designated as not applicable for trial phase. Mazdutide remains an unapproved compound under research and is not approved for general use.
According to the registry entry, the trial is actively recruiting participants as of the listed date. No outcome data, efficacy results, or safety findings have been reported for this study at this stage. The trial record does not include additional details beyond its title, status, phase designation, and registration identifier.
This update reflects only the recruitment status reported in the trial registry. It does not indicate any conclusions about mazdutide's effects when combined with lifestyle intervention for weight management. Readers should note that recruiting status means the trial is open for participant enrollment and has not yet produced results.
For more background on this compound, readers can consult the mazdutide overview page.